Life Sciences

Swedish researchers found that children from low-income households are 41% more likely to develop diabetic ketoacidosis when diagnosed with type 1 diabetes. The finding, based on national health records, suggests healthcare systems may need targeted screening and intervention strategies for disadvantaged populations to prevent life-threatening complications at disease onset.EN

Researchers found that a modified version of rituximab—a widely used lymphoma drug—weakens tumors' defenses against immune attack, potentially making existing treatments far more effective. The discovery could extend drug life cycles and improve patient outcomes without developing entirely new therapies, offering immediate clinical and commercial implications for cancer treatment.EN

Researchers have designed a microscopic trap that captures individual disease-carrying particles from blood and makes them glow brighter, solving a major obstacle to using these particles as reliable diagnostic tools. The advance could accelerate development of blood tests that detect diseases earlier and more accurately than existing methods.EN

Scientists have mapped how amyloid proteins damage the heart and identified biomarkers that could transform patient management in systemic amyloidoses, a group of rare but often fatal diseases. These discoveries are accelerating drug development and could expand treatment options for conditions that currently lack effective therapies, opening a significant market opportunity for diagnostics and therapeutics.EN

Researchers analyzing 2,550 Swedish breast cancer patients have found a previously unknown genetic risk factor and confirmed three others, suggesting the need to revamp how doctors assess cancer vulnerability. The discovery could reshape genetic testing strategies and personalized medicine approaches for cancer prevention in coming years.EN

Researchers have developed a new class of therapeutic compounds that directly invade and bind to DNA to silence disease-causing genes, demonstrating success against huntingtin—the faulty protein driving Huntington's disease. The advance could expand treatment options for genetic disorders currently lacking effective therapies, opening a significant market opportunity for biotech companies developing precision genetic medicines.EN

A new study found that lidocaine, a common seizure treatment in neonatal intensive care units, does not cause lasting behavioral problems in early life exposure. The finding provides reassurance to hospitals and regulators about the safety profile of this widely used drug in premature infants.EN

A Swedish study of students, teachers, and parents reveals that autism diagnoses in educational settings cut both ways: they can help schools recognize diversity and adapt support, or they can inadvertently cap what students are expected to achieve. The finding matters for school districts and policymakers designing inclusive education programs.EN

Researchers have identified the key molecular machinery behind callose, a vital compound that controls plant growth and disease resistance. The breakthrough opens a path to engineering plants that are hardier and more productive—potentially reshaping agriculture and food security strategies.EN

A study of Swedish primary care physicians found that doctors can significantly reduce unnecessary antibiotic prescribing for respiratory infections without harming outcomes. The findings offer a roadmap for healthcare systems struggling with antibiotic resistance—a problem costing economies billions annually—by identifying which physician practices and patient factors drive overprescribing.EN

Researchers combined machine learning with physics simulations to map how repeated amino acids fold into dangerous structures. The finding explains why certain genetic mutations trigger neurodegenerative diseases and could guide drug developers toward new therapeutic targets for conditions like Huntington's disease.EN

Researchers used long-read genome sequencing to pinpoint the exact breakpoints of complex DNA duplications linked to autism spectrum disorder in five families—a breakthrough that had eluded conventional methods. The findings could accelerate genetic diagnosis and understanding of how abnormal gene duplications contribute to autism, opening doors for better clinical testing and potential therapeutic targets.EN

Researchers have identified the precise mechanism by which cells break down a key growth signal receptor, PDGFRβ, which could reshape how companies approach cancer drug development. The finding suggests existing cancer therapies may need redesign, since blocking this degradation pathway affects multiple signaling routes simultaneously—a critical consideration for minimizing side effects.EN

Researchers have engineered a microchip that identifies tiny disease-carrying particles in blood with unprecedented sensitivity, potentially enabling faster disease diagnosis at lower cost. The silicon-based device could accelerate development of point-of-care diagnostic tools for cancer, heart disease, and other conditions where early detection saves lives and reduces treatment expenses.EN

Researchers found that people who adhered closely to Swedish dietary guidelines had more diverse gut bacteria and were significantly less likely to develop metabolic syndrome—a cluster of conditions that increases diabetes and heart disease risk. The discovery suggests diet quality shapes microbial health in ways that could prevent costly chronic diseases.EN

Researchers are questioning a widespread belief about how plasmonic materials boost chemical reactions—a finding that could redirect billions in cleantech investment. The study reveals that scientists often credit a flashy mechanism called "hot carriers" without properly testing alternatives, risking development of inefficient technologies.EN

Researchers have created an injectable hydrogel that heals itself after injection, stays stable for years, and safely dissolves in the body—solving three longstanding problems in regenerative medicine. The breakthrough could accelerate tissue engineering therapies and reduce development timelines for companies working on cell-based treatments and wound care.EN

Researchers have determined how many days of saliva sampling are needed to reliably measure stress hormones in dementia patients and their caregivers—a finding that could cut costs and complexity in clinical trials. The study suggests that five consecutive days of morning cortisol collection provides sufficient data to detect meaningful treatment effects, streamlining trial design without sacrificing statistical rigor.EN

A major Scandinavian study of over 81,000 children reveals that good diet quality in infancy reduces inflammatory bowel disease risk by roughly a quarter. The finding could reshape pediatric nutritional guidance and reshape market demand for premium infant foods formulated to prevent chronic disease.EN

Scientists across 33 European countries have successfully tested a decentralized approach to sequencing reference genomes for 98 species, offering a blueprint for scaling biodiversity genomics globally. The model addresses a critical gap: less than 1% of Earth's 1.5 million eukaryotic species have high-quality genetic maps, limiting drug discovery, conservation efforts, and agricultural innovation.EN

Researchers have identified a drug candidate that suppresses tumor growth in medulloblastoma, the most common pediatric brain cancer. By targeting an enzyme involved in cell metabolism rather than directly attacking the cancer gene itself, the approach shows promise for patients with the most aggressive forms of the disease, potentially opening a new treatment pathway.EN

A new study found that combat pilots significantly underestimate their aircraft's roll angle during high-G turns, and this varies wildly between individuals. The research suggests pilot training programs may need to focus more on spatial awareness, with implications for flight safety protocols and simulator design.EN

Researchers have decoded the binding patterns of a vast family of enzymes called medium-chain dehydrogenases, identifying which molecular features drive their diverse functions. The breakthrough could accelerate drug development by helping companies design better therapies and predict how candidate compounds will interact with human proteins.EN

Scientists have pinpointed a panel of blood biomarkers that could streamline how companies and clinicians monitor whether gene therapies for Duchenne muscular dystrophy are actually working. The discovery could accelerate drug development timelines and reduce the need for invasive muscle biopsies in clinical trials.EN

Researchers found that cationic and anionic lipid additives prompt fundamentally different immune pathways in intranasal flu vaccines—one boosting cellular immunity, the other antibody production. The discovery could let manufacturers design shots targeted to specific populations or flu variants, potentially improving vaccination outcomes across age groups and risk categories.EN